Boudreaux Gail insider trades
Boudreaux Gail has filed 15 Form 4s with the SEC that we hold, for Elevance Health, Inc. (ELV) (President and CEO, Director) and Target Corp (TGT) (Director). Across all of them we count 5 purchases worth $3.4M and 6 sales worth $17.0M reported on Form 4. In the last 12 months: 2 purchases ($1.0M) and 0 sales ($0). The largest single trade was a sale of 20,779 shares of Elevance Health, Inc. worth $10.4M, dated 2024-07-22. The first filing on our record is dated 2021-09-24 and the latest 2026-07-17.
Elevance Health, Inc. (ELV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-07-22 | S, sale reported on Form 4 | 1,000 | $503.7K | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 2,250 | $1.1M | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 6,621 | $3.3M | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 2,250 | $1.1M | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 1,100 | $548.4K | 2024-07-23 |
| 2024-07-22 | S, sale reported on Form 4 | 20,779 | $10.4M | 2024-07-23 |
| 2025-07-18 | P, purchase reported on Form 4 | 2,334 | $667.7K | 2025-07-18 |
| 2025-07-18 | P, purchase reported on Form 4 | 5,116 | $1.5M | 2025-07-18 |
| 2025-07-18 | P, purchase reported on Form 4 | 1,050 | $302.4K | 2025-07-18 |
| 2026-07-17 | P, purchase reported on Form 4 | 680 | $249.2K | 2026-07-17 |
| 2026-07-17 | P, purchase reported on Form 4 | 2,045 | $753.1K | 2026-07-17 |
Target Corp (TGT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1287920) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms